There are times when one person is totally at fault in an accident. For instance, imagine a motorist running a…
Read More →
Litigation risks associated with per and polyfluoroalkyl substances (PFAS) continue to grow, as demonstrated by settlements over the last year…
Read More →
Wegovy and other GLP-1 medications have become extremely popular over the past few years. Novo Nordisk (which makes both Wegovy…
Read More →
On December 9. 2024, Sabre GLBL Inc. filed a notice of data breach with the Attorney General of Maine after…
Read More →
The updated Directive aims to modernize the existing liability regime, in particular in the light of past and future technological…
Read More →
On November 26, 2024, the United States Court of Appeals for the Fifth Circuit issued a landmark decision holding that…
Read More →
Because the United States has so far adopted a light-handed and decentralized approach to regulating artificial intelligence (AI) in the…
Read More →
During a recent meeting with Michael Quartararo, president of ACEDS, and Maribel Rivera, VP of Strategy and Client Engagement at…
Read More →
For most of the last two decades, the U.S. Patent and Trademark Office offered its electronic filing system (EFS), through…
Read More →
Allermi, a San Francisco-based telehealth company, is redefining personalized allergy care by offering compounded nasal spray products that combine multiple…
Read More →